Category Archive for “Civil Society”
1 - 10 of 15 posts

Is technology transfer for Northern businesses or Southern countries?

Tuesday, December 15th, 2009

I am still in the Bella Centre, still tracking technology negotiations.  That means I have a magical “secondary pass” unlike thousands of other NGOs who cannot get into the building today. Technology is supposed to be the “easy issue”, on which there will possibly be an agreement, evoked by both the Danish Presidency and the [...]

Read the rest of this entry

After the demo … and tangling with the Royal Society

Sunday, December 13th, 2009

So much has happened in the past three days it is has been impossible to blog.  We have been trying to lobby for precaution and assessment on technology, trying to talk to the press about our issues, attending side events, organizing our own workshops, meeting old and new friends and allies and basically working from [...]

Read the rest of this entry

Leaving for Copenhagen – yikes

Monday, December 7th, 2009

It is the mad dash for Copenhagen.
I am leaving Montreal for the international summit tomorrow although the conference actually got underway today.  In between urgent emails over the weekend I found the time to take my ten year old daughter and two of her friends to see A Christmas Carol, a Geordie Theatre production of [...]

Read the rest of this entry

Microbios, gripe y puercos trasnacionales

Monday, July 20th, 2009

Silvia Ribeiro*
Aunque los casos comprobados de gripe porcina humana llegan a más de 100 mil en el mundo y se teme que las próximas mutaciones del virus lo harán más letal, los gobiernos y la Organización Mundial de la Salud (OMS) se esfuerzan en ignorar las causas reales de la pandemia.
En lugar de ello, predominan [...]

Read the rest of this entry

La farsa del mapa genómico de los mexicanos

Monday, May 25th, 2009

Silvia Ribeiro*
El pasado 11 de mayo, el Instituto Nacional de Medicina Genómica (Inmegen) presentó en un acto mediático, con la presencia entusiasta de Felipe Calderón, el llamado “Mapa del genoma de los mexicanos”. Se presentó como un gran avance científico, vinculándolo oportunistamente hasta con el estudio del virus de la gripe porcina. Obviaron sin embargo [...]

Read the rest of this entry

Premiando a las trasnacionales de la epidemia

Saturday, May 9th, 2009

Silvia Ribeiro*
Pese a la manipulación de información por parte de autoridades e industria, es inocultable que el actual virus de gripe porcina (ahora asépticamente llamado de influenza A/H1N1) tiene su origen en la producción industrial de animales.
Las autoridades conocían la amenaza de pandemia, pero no dieron importancia a los avisos de instituciones científicas y organizaciones [...]

Read the rest of this entry

La contaminación transgénica como negocio

Sunday, March 15th, 2009

Silvia Ribeiro*
El 6 de marzo, el gobierno mexicano anunció que consideraba terminado (en todos los sentidos de la palabra) el marco legal de bioseguridad en México, abriendo las puertas a la experimentación con maíz transgénico. Un delito histórico, que marca la decisión del gobierno de enajenar y colocar en alto riesgo el patrimonio genético alimentario [...]

Read the rest of this entry

Jolly gene giant-a book review of Claire Hope Cummings’ “Uncertain Peril”

Tuesday, May 6th, 2008

Review by Hope Shand, research director of ETC Group.
—–
In October 1996, a spokesman for Monsanto told Farm Journal why his company was buying up seed companies left and right: “What you’re seeing is not just a consolidation of seed companies, it’s really a consolidation of the entire food chain.”
Today, Monsanto is the world’s largest seed [...]

Read the rest of this entry

Parting with parts

Tuesday, June 26th, 2007

“I think this is going to become the foundational technology of the 21st century” – that was the triumphant message with which Tom Knight of MIT brought Synthetic Biology 3.0 to an end today. An engineering generalist who moved from artificial intelligence to artificial life, it was Knight who, along with Drew Endy, developed [...]

Read the rest of this entry

FDA’s Little Meeting

Thursday, October 12th, 2006

On October 10, ETC Group attended the US Food and Drug Administration’s first public meeting on nanotechnology. About 40 people had signed up to make presentations, and we were each given eight minutes to say our piece to the FDA’s newly-formed Nanotechnology Task Force. (You can read the text of ETC Group’s presentation here.)
It [...]

Read the rest of this entry